IMMUNITYBIO
Live / Applied — Ex parte appeal pending (as of 26 Mar 2026)
What this means for you
Not registered yet, but its 16 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97594955
- Mark type
- Stylized text
- Filed
- 16 Sept 2022
- Attorney of record
- MICHAEL J. MCCUE
Goods and services
- Class 042 — Scientific and technological services: Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases
Owner
- NANTCELL, INC., Culver City, CA, US
Prior registrations
Prosecution history
- 31 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Mar 2026 — ASSIGNED TO LIE
- 26 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 26 Mar 2026 — EX PARTE APPEAL-INSTITUTED
- 26 Mar 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 26 Mar 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 02 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 02 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 02 Oct 2025 — FINAL REFUSAL E-MAILED
- 02 Oct 2025 — FINAL REFUSAL WRITTEN
- 01 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED